These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 30515161)
1. Protection Against Invasive Infections in Children Caused by Encapsulated Bacteria. Sadarangani M Front Immunol; 2018; 9():2674. PubMed ID: 30515161 [TBL] [Abstract][Full Text] [Related]
2. Antibody repertoires in infants and adults: effects of T-independent and T-dependent immunizations. Adderson EE Springer Semin Immunopathol; 2001 Dec; 23(4):387-403. PubMed ID: 11826616 [TBL] [Abstract][Full Text] [Related]
3. Induction of Susceptibility to Disseminated Infection with IgA1 Protease-Producing Encapsulated Pathogens Streptococcus pneumoniae, Haemophilus influenzae Type b, and Neisseria meningitidis. Kilian M; Husby S; Andersen J; Moldoveanu Z; Sørensen UBS; Reinholdt J; Tettelin H mBio; 2022 Jun; 13(3):e0055022. PubMed ID: 35420467 [TBL] [Abstract][Full Text] [Related]
4. The changing epidemiology of bacterial meningitis and invasive non-meningitic bacterial disease in scotland during the period 1983-99. Kyaw MH; Christie P; Jones IG; Campbell H Scand J Infect Dis; 2002; 34(4):289-98. PubMed ID: 12064693 [TBL] [Abstract][Full Text] [Related]
5. The multifunctional role of antibodies in the protective response to bacterial T cell-independent antigens. Mond JJ; Kokai-Kun JF Curr Top Microbiol Immunol; 2008; 319():17-40. PubMed ID: 18080413 [TBL] [Abstract][Full Text] [Related]
6. An association between homozygous C3 deficiency and low levels of anti-pneumococcal capsular polysaccharide antibodies. Hazlewood MA; Kumararatne DS; Webster AD; Goodall M; Bird P; Daha M Clin Exp Immunol; 1992 Mar; 87(3):404-9. PubMed ID: 1544226 [TBL] [Abstract][Full Text] [Related]
7. Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines. Pollard AJ; Perrett KP; Beverley PC Nat Rev Immunol; 2009 Mar; 9(3):213-20. PubMed ID: 19214194 [TBL] [Abstract][Full Text] [Related]
8. Mucosal vaccination against encapsulated respiratory bacteria--new potentials for conjugate vaccines? Jakobsen H; Jonsdottir I Scand J Immunol; 2003 Aug; 58(2):119-28. PubMed ID: 12869132 [TBL] [Abstract][Full Text] [Related]
9. Pediatric bacterial meningitis in Japan, 2013-2015 - 3-5 years after the wide use of Haemophilus influenzae type b and Streptococcus pneumoniae conjugated vaccines. Shinjoh M; Yamaguchi Y; Iwata S J Infect Chemother; 2017 Jul; 23(7):427-438. PubMed ID: 28456490 [TBL] [Abstract][Full Text] [Related]
10. Long-term protection after immunization with protein-polysaccharide conjugate vaccines in infancy. Blanchard-Rohner G; Pollard AJ Expert Rev Vaccines; 2011 May; 10(5):673-84. PubMed ID: 21604987 [TBL] [Abstract][Full Text] [Related]
11. Immunologic priming to capsular polysaccharide in infants immunized with Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine. Weinberg GA; Einhorn MS; Lenoir AA; Granoff PD; Granoff DM J Pediatr; 1987 Jul; 111(1):22-7. PubMed ID: 3110388 [TBL] [Abstract][Full Text] [Related]
12. Polyosides (encapsulated bacteria). Lindberg AA C R Acad Sci III; 1999 Nov; 322(11):925-32. PubMed ID: 10646085 [TBL] [Abstract][Full Text] [Related]
13. Hospital admission rates for meningitis and septicaemia caused by Haemophilus influenzae, Neisseria meningitidis, and Streptococcus pneumoniae in children in England over five decades: a population-based observational study. Martin NG; Sadarangani M; Pollard AJ; Goldacre MJ Lancet Infect Dis; 2014 May; 14(5):397-405. PubMed ID: 24631222 [TBL] [Abstract][Full Text] [Related]
14. A Narrative Review of the Molecular Epidemiology and Laboratory Surveillance of Vaccine Preventable Bacterial Meningitis Agents: Tsang RSW Microorganisms; 2021 Feb; 9(2):. PubMed ID: 33671611 [TBL] [Abstract][Full Text] [Related]
15. Differential regulation of polysaccharide-specific antibody responses to isolated polysaccharides, conjugate vaccines, and intact Gram-positive versus Gram-negative extracellular bacteria. Snapper CM Vaccine; 2016 Jun; 34(30):3542-8. PubMed ID: 27133879 [TBL] [Abstract][Full Text] [Related]
16. [Immunological principles of polysaccharide-protein conjugate vaccination]. Meyer M; Gahr M Monatsschr Kinderheilkd; 1993 Oct; 141(10):770-6; quiz 777, 812-3. PubMed ID: 7505396 [TBL] [Abstract][Full Text] [Related]
17. The unspecific antibody response to N. meningitidis group A capsular polysaccharide often seen in bacteraemic diseases. Käyhty H Parasite Immunol; 1982 May; 4(3):157-70. PubMed ID: 6808441 [TBL] [Abstract][Full Text] [Related]
18. Fisher scientific award lecture - the capsular polysaccharides of Group B Streptococcus and Streptococcus suis differently modulate bacterial interactions with dendritic cells. Segura M Can J Microbiol; 2012 Mar; 58(3):249-60. PubMed ID: 22356626 [TBL] [Abstract][Full Text] [Related]
19. Challenges for the development of vaccines against Haemophilus influenzae and Neisseria meningitidis. Cripps AW; Foxwell R; Kyd J Curr Opin Immunol; 2002 Oct; 14(5):553-7. PubMed ID: 12183152 [TBL] [Abstract][Full Text] [Related]
20. Haemophilus influenzae: surface antigens and aspects of virulence. Munson RS Can J Vet Res; 1990 Apr; 54 Suppl():S63-7. PubMed ID: 2193707 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]